Effect of beta-lactam antibiotics of the resistance of the digestive tract of mice to colonization.
Four broad-spectrum antibiotics-azlocillin, mezlocillin, cefuroxime, and moxalactam - were injected subcutaneously into mice twice a day. The animals divided into treatment groups for each antibiotic and then into subgroups, each subgroup receiving a different dose of antibiotic. The effect of treatment on the resistance of the digestive tract to colonization and the effect of treatment on endogenous gram-negative and intestinal streptococcal flora was studied: resistance to colonization decreased during treatment with approximately 0.9 mg of antibiotic per mouse per day. During treatment with this dose or a higher dose, Escherichia coli or a strain of Enterobacter resistant to the antibiotic being used grew to significantly higher numbers per gram of feces than in the control groups. The resistance of the digestive tract to colonization in mice decreases during systemic treatment with all four antibiotics at or above certain dose levels, a result also likely to occur in humans.
D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D001390:Azlocillin; D002444:Cefuroxime / Q000494:pharmacology; D002513:Cephamycins / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D004754:Enterobacter / Q000254:growth & development; D004755:Enterobacteriaceae / Q000254:growth & development*; D013293:Enterococcus faecalis / Q000254:growth & development*; D004926:Escherichia coli / Q000254:growth & development; D005243:Feces / Q000382:microbiology; D005260:Female; D007422:Intestines / Q000187:drug effects / Q000382:microbiology*; D008802:Mezlocillin; D051379:Mice; D009070:Moxalactam; D010406:Penicillins / Q000494:pharmacology; D047090:beta-Lactams / Q000494:pharmacology
D000900:Anti-Bacterial Agents; D002513:Cephamycins; D010406:Penicillins; D047090:beta-Lactams; D001390:Azlocillin; D002444:Cefuroxime; D008802:Mezlocillin; D009070:Moxalactam